Role of Human papilloma virus Infection and Altered Methylation of Specific Genes in Esophageal Cancer

  • Mohiuddin, Mohammed Khaliq (Department of Genetics, Vasavi Medical and Research Centre, Kamineni Hospitals) ;
  • Chava, Srinivas (Department of Genetics, Vasavi Medical and Research Centre, Kamineni Hospitals) ;
  • Upendrum, Pavani (Department of Genetics and Molecular Medicine, Kamineni Hospitals) ;
  • Latha, Madhavi (Department of Genetics, Vasavi Medical and Research Centre, Kamineni Hospitals) ;
  • Zubeda, Syeda (Department of Genetics, Vasavi Medical and Research Centre, Kamineni Hospitals) ;
  • Kumar, Ajith (Department of Gastroenterology, Nizam's Institute of Medical Sciences) ;
  • Ahuja, Yog Raj (Department of Genetics, Vasavi Medical and Research Centre, Kamineni Hospitals) ;
  • Hasan, Qurratulain (Department of Genetics, Vasavi Medical and Research Centre, Kamineni Hospitals) ;
  • Mohan, Vasavi (Department of Genetics, Vasavi Medical and Research Centre, Kamineni Hospitals)
  • Published : 2013.07.30


Background: Evaluation of Human papilloma virus (HPV) and its association with promoter methylation of candidate genes, p53 and Aurora A in esophageal cancer. Materials and Methods: One hundred forty-one esophageal tissue samples from different pathologies were evaluated for HPV infection by PCR, while the promoter methylation status of p53 and Aurora A was assessed by methylation-specific restriction based PCR assay. Statistical analyses were performed with MedCalc and MDR software. Results: Based on endoscopy and histopathology, samples were categorized: cancers (n=56), precancers (n=7), esophagitis (n=19) and normals (n=59). HPV infection was found to be less common in cancers (19.6%), whereas its prevalence was relatively high in precancers (71.4%), esophagitis (57.8%) and normals (45.7%). p53 promoter methylation did not show any significant difference between cancer and normal tissues, whereas Aurora A promoter methylation demonstrated significant association with disease (p=0.00016, OR:5.6452, 95%CI:2.18 to 14.6) when compared to normals. Aurora A methylation and HPV infection was found in a higher percentages of precancer (66.6%), esophagitis (54.5%) and normal (45.2%) when compared to cancers (14.2%). Conclusions: Aurora A promoter methylation is significantly associated with esophageal cancer, but the effect of HPV infection on this epigenetic alteration is not significant. However MDR analysis showed that the hypostatic effect of HPV was nullified when the cases had Aurora methylation and tobacco exposure. Further HPV sub-typing may give an insight into its reduced prevalence in esophageal cancer verses normal tissue. However, with the present data it is difficult to assign any significant role to HPV in the etiopathology of esophageal cancer.


Human papilloma virus (HPV);p53;Aurora A;methylation;esophageal cancer


  1. Abdolvahab M, Mokhtari-Azad T (2006). Detection of HPV in cancerous and non cancerous esophageal tissue from Turkmen-Sahra, Iran. Int J Cancer Res, 2, 113-8.
  2. Ahmed HG, Mustafa SA, Warille E (2012). Human papilloma virus attributable head and neck cancer in the Sudan assessed by p16INK4A Immunostaining. Asian Pac J Cancer Prev, 13, 6083-6.
  3. Alam S, Conway MJ, Chen HS, et al (2008). The cigarette smoke carcinogen Benzo [a] pyrene enhances human papillomavirus synthesis. J Virol, 82, 1053-8.
  4. Bahnassy AA, Zekri AR, Madbouly MS, et al (2006). The correlation between FHIT, p53 and MMR genes in human papillomavirus-associated cervical carcinoma. J Egypt Natl Canc Inst, 3, 191-202.
  5. Burum-Auensen E, Skotheim RI, Schjolberg AR, et al (2010). Spindle proteins are differentially expressed in the various histological subtypes of testicular germ cell tumors. J Carcinog, 9, 1.
  6. Buyru N, Tezol A, Dalay N (2006). Coexistence of K-ras mutations and HPV infection in colon cancer. BMC Cancer, 6, 115.
  7. Castillo A, Koriyama C, Higashi M, et al (2011). Human papillomavirus in upper digestive tract tumors from three countries. World J Gastroenterol, 17, 5295-304.
  8. Chava, S, Kaliq MD, Nagarjuna P, et al (2011). Epigenetics and esophageal cancer: role of altered methylation in specific genes. Int J Cancer Res, [Epub ahead of print].
  9. Chen SS, Chang PC, Cheng YW, et al (2002). Suppression of the STK15 oncogenic activity requires a transactivation-independent p53 function. EMBO J, 21, 4491-9.
  10. Chen XB, Chen GL, Liu JN, et al (2009). Genetic polymorphisms in STK15 and MMP-2 associated susceptibility to esophageal cancer in Mongolian population. Zhonghua Yu Fang Yi Xue Za Zhi, 43, 559-64.
  11. Cogliano V, Baan R, Straif K, et al (2005). WHO International Agency for Research on Cancer (2005). Carcinogenicity of human papillomaviruses. Lancet Oncol, 6, 204.
  12. Dabrowski A, Kwasniewski W, Skoczylas T, et al (2012). Incidence of human papilloma virus in esophageal squamous cell carcinoma in patients from the Lublin region. World J Gastroenterol, 18, 5739-44.
  13. de Villiers EM, Gunst K, Stein H, et al (2004). Esophageal squamous cell cancer in patients with head and neck cancer: Prevalence of human papillomavirus DNA sequences. Int J Cancer, 109, 253-8.
  14. de Wilde J, Kooter JM, Overmeer RM, et al (2010). hTERT promoter activity and CpG methylation in HPV-induced carcinogenesis. BMC Cancer, 10, 27.
  15. Dolgin E (2011). Sequencing reveals suite of commensal and pathogenic viruses. Nat Med, 17, 399.
  16. Engel LS, Chow WH, Vaughan TL, et al (2003). Population attributable risks of esophageal and gastric cancer. J Natl Cancer Inst, 95, 1404-13.
  17. Farhadi M, Tahmasebi Z, Merat S, et al (2005). Human papillomavirus in squamous cell carcinoma of esophagus in a high- risk population. World J Gastroenterol, 11, 1200-3.
  18. Ferlay J, Shin HR, Bray F, et al (2010). Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer, 127, 2893-917.
  19. Flatley JE, McNeir K, Balasubramani L, et al (2009). Folate status and aberrant DNA methylation are associated with HPV infection and cervical pathognesis. Cancer Epidemiol Biomarkers Prev, 18, 2782-9.
  20. Furihata M, Ohtsuki Y, Ogoshi S, et al (1993). Prognostic significance of human papillomavirus genomes (type-16,-18) and aberrant expression of p53 protein in human esophageal cancer. Int J Cancer, 54, 226-30.
  21. Gillison ML, Koch WM, Capone RB, et al (2000). Evidence for a causal association between human papillomavirus and a subset of head and neck cancers. J Natl Cancer Inst, 92, 709-20.
  22. Goto A, Li CP, Ota S, et al (2011). Human papillomavirus infection in lung and esophageal cancers: analysis of 485 Asian cases. J Med Virol, 83, 1383-90.
  23. Gravitt PE, Paul P, Katki HA, et al (2010). Effectiveness of VIA, Pap, and HPV DNA testing in a cervical cancer screening program in a peri-urban community in Andhra Pradesh, India. PLoS One, 5, 13711.
  24. Haeri H, Mardany O, Asadi-Amoli F, et al (2013). Human papilloma virus and esophageal squamous cell carcinoma. Acta Med Iran, 51, 242-5.
  25. He D, Zhang DK, Lam KY, et al (1997). Prevalence of HPV infection in esophageal squamous cell carcinoma in Chinese patients and its relationship to the p53 gene mutation. Int J Cancer, 72, 959-64.<959::AID-IJC7>3.0.CO;2-O
  26. Henken FE, Wilting SM, Overmeer RM, et al (2007). Sequential gene promoter methylation during HPV-induced cervical carcinogenesis. Br J Cancer, 97, 1457-64.
  27. Hodge DR, Peng B, Cherry JC, et al (2005). Interleukin 6 supports the maintenance of p53 tumor suppressor gene promoter methylation. Cancer Res, 65, 4673-82.
  28. Ibrahim MA (2010). Perspective of DNA Methylation in Cancer Research. Int J Cancer Res, 6, 188-201.
  29. Islami F, Boffetta P, Ren JS, et al (2009). High temperature beverages and foods and esophageal cancer risk- a systematic review. Int J Cancer, 125, 491-524.
  30. Jemal A, Bray F, Center MM, et al (2011). Global cancer statistics. CA Cancer J Clin, 61, 69-90.
  31. Kang JH, Kim SJ, Noh DY, et al (2001). Methylation in the p53 promoter is a supplementary route to breast carcinogenesis: correlation between CpG methylation in the p53 promoter and the mutation of the p53 gene in the progression from ductal carcinoma in situ to invasive ductal carcinoma. Lab Invest, 81, 573-9.
  32. Katayama H, Sasai K, Kawai H, et al (2004). Phosphorylation by aurora kinase A induces Mdm2-mediated destabilization and inhibition of p53. Nat Genet, 36, 55-62.
  33. Katiyar S, Hedau S, Jain N, et al (2005). p53 gene mutation and human papillomavirus (HPV) infection in esophageal carcinoma from three different endemic geographic regions of India. Cancer Lett, 218, 69-79.
  34. Koshiol Jill, Kreimer AR (2010). Lessons from Australia: human papillomavirus is not a major risk factor for esophageal squamous cell carcinoma. Cancer Epidemiol Biomarkers Prev, 19, 1889-92.
  35. Lin-Yu Lu, Wood JL, Lin Ye, et al (2008). Aurora A is essential for early embryonic development and tumor suppression. J Biol Chem, 283, 31785-90.
  36. Liu Q, Kaneko S, Yang L, et al (2004). Aurora-A abrogation of p53 DNA binding and transactivation activity by phosphorylation of serine 215. J Biol Chem, 279, 52175-82.
  37. Liu T, Liu Q, Liang M, et al (2012). Viral load of HPV 16/18 in esophageal squamous cell carcinoma in three ethnic groups living in Xinjiang Autonomous Region, China. Mol Biol Rep, 40, 2045-52.
  38. Mancilla LI, Carrascal E, Tomayo OM, et al (2011). Role of human papillomavirus type 16 in squamous cell carcinoma of upper aerodigestive tracts in Colombian patients. Int J Cancer Res, 7, 222-32.
  39. Marumoto T, Honda S, Hara T, et al (2003). Aurora-A kinase maintains the fidelity of early and late mitotic events in HeLa cells. J Biol Chem, 278, 51786-95.
  40. Mass MJ, Wang L (1997). Arsenic alters cytosine methylation patterns of the Promoter of the tumor suppressor gene p53 in human lung cells: a model for a mechanism of carcinogenesis. Mutat Res, 386, 263-77.
  41. Mir MM, Dar JA, Dar NA, et al (2007). The Association of Beta-catenin Gene Mutations and Human Papillomavirus in Carcinoma of Esophagus in a High-Risk Population of India. Int J Health Sci (Qassim), 2, 177-83.
  42. Mohan V, Ponnala S, Gujjari K, et al (2006). DNA methylation in esophageal diseases including cancer: special reference to hMLH1 gene promoter status. Tumori, 92, 155-62.
  43. Mohan V, Ponnala S, Reddy HM, et al (2007). Chromosome 11 aneusomy in esophageal cancers and precancerous lesions an early event in neoplastic transformation: an interphase fluorescence in situ hybridization study from south India. World J Gastroenterol, 13, 503-8.
  44. Nordenstedt H, El-Serag H (2011). The influence of age, sex and race on the incidence of esophageal cancer in the United States (1992-2006). Scand J Gastroenterol, 46, 597-602.
  45. Puttawibul P, Chanvitan A, Pornpatanarak C, Sangthong B (2001). Esophageal carcinoma in Southern Thailand. J Med Assoc Thai, 84, 1-5.
  46. Schafer G, Kabanda S, van Rooyen B, et al (2013). The role of inflammation in HPV infection of the Oesophagus. BMC Cancer, 13, 185.
  47. Schroeder M, Mass MJ (1997). CpG methylation inactivates the transcriptional activity of the promoter of the human p53 tumor suppressor gene. Biochem Biophys Res Commun, 235, 403-6.
  48. Shetty PJ, Movva S, Pasupuleti N, et al (2011). Regulation of IGF2 transcript and protein expression by altered methylation in breast cancer. J Cancer Res Clin Oncol, 137, 339-45.
  49. Shukla S, Bharti AC, Mahata S, et al (2009). Infection of human papilloma viruses in cancers of different human organs sites. Indian J Med Res, 130, 222-3.
  50. Sitas F, Egger S, Urban MI, et al (2012). InterSCOPE study: associations between esophageal squamous cell carcinoma and human papillomavirus serological markers. J Natl Cancer Inst, 104, 147-58.
  51. Suzuk L, Noffsinger AE, Hui YZ, Fenoglio-Preiser CM (1996). Detection of human papillomavirus in esophageal squamous cell carcinoma. Cancer, 78, 704-10.<704::AID-CNCR2>3.0.CO;2-E
  52. Syrjanen K, Pyrhonen S, Aukee S, Koskela E (1982). Squamous cell papilloma of the esophagus: a tumour probably caused by human papilloma virus (HPV). Diagn Histopathol, 5, 291-6.
  53. Toh Y, Oki E, Ohgaki K, et al (2010). Alcohol drinking, cigarette smoking, and the development of squamous cell carcinoma of the esophagus: molecular mechanisms of carcinogenesis. Int J Clin Oncol, 15, 135-44.
  54. Vaiphei K, Kochhar R, Bhardawaj S, et al (2012). High prevalence of human papillomavirus in esophageal squamous cell carcinoma: a study in paired samples. Dis Esophagus, 26, 282-7.
  55. Woodson K, Mason J, Choi SW, et al (2001). Hypomethylation of p53 in peripheral blood DNA is associated with the development of lung cancer. Cancer Epidemiol Biomarkers Prev, 10, 69-74.
  56. Wu M, Liu AM, Kampman E, et al (2009). Green tea drinking, high tea temperature and esophageal cancer in high-and low risk areas of Jiangsu Province, China: a population- based case-control study. Int J Cancer, 124, 1907-13.
  57. Xian WJ, Sikon A, Yen-Liberman B (2011). Cervical cancer screening: Less testing, smarter testing. Clev Clin J Med, 78, 737-47.
  58. Yahyapour Y, Shamsi-Shahrabadi M, Mahmoudi M, et al (2012). Evaluation of human papilloma virus infection in patients with esophageal squamous cell carcinoma from the Caspian Sea area, north of Iran. Asian Pac J Cancer Prev, 13, 1261-6.
  59. Yang J, Liu B, Li W, et al (2013). Association of p53 and MDM2 polymorphisms with risk of human papillomavirus (HPV)-related esophageal squamous cell carcinoma (ESCC). Cancer Epidemiol, [Epub ahead of print].
  60. Zandberg DP, Bhargava R, Badin S, Cullen KJ (2013).The role of human papillomavirus in nongenital cancers. CA Cancer J Clin, 63, 57-81.
  61. Zhao Y, Chen XQ, Du JZ (2009). Cellular adaptation to hypoxia and p53 transcription regulation. J Zhejiang Univ Sci B, 10, 404-10.
  62. zur Hausen H, de Villiers EM (1994). Human papillomaviruses. Annu Rev Microbiol, 48, 427-47.

Cited by

  1. C13orf18 and C1orf166 (MULAN) DNA Genes Methylation are Not Associated with Cervical Cancer and Precancerous Lesions of Human Papillomavirus Genotypes in Iranian Women vol.15, pp.16, 2014,
  2. Analysis of TP53 Polymorphisms in North Indian Sporadic Esophageal Cancer Patients vol.15, pp.19, 2014,
  3. Prevalence of Human Papillomavirus 16 in Esophageal Cancer Among the Chinese Population: a Systematic Review and Meta-analysis vol.15, pp.23, 2015,
  4. Epidemic Trends of Upper Gastrointestinal Tract Abnormalities: Hospital-based study on Endoscopic Data Evaluation vol.16, pp.14, 2015,
  5. p16 Expression as a Surrogate Marker for HPV Infection in Esophageal Squamous Cell Carcinoma can Predict Response to Neo-Adjuvant Chemotherapy vol.16, pp.16, 2015,
  6. Association of human papillomavirus type 58 with breast cancer in shaanxi province of China vol.87, pp.6, 2015,
  7. Amplification of specific chromosomal regions assessed by fluorescent in situ hybridization on Pap smears to be added as screening tool for identifying women at risk of progressing to cervical cancer vol.39, pp.10, 2017,